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ABSTRACT 
Background: It is unclear if patients with specific subgingival microbiological profiles 
benefit more from adjunctive systemic antibiotics.  
Aims: To answer the question: ‘What is the clinical benefit in periodontitis patients taking 
adjunctive systemic antimicrobials to non-surgical therapy, depending on pre-treatment 
detection of periodontopathogenic bacteria?’ 
Materials and Methods: A search was conducted in 4 electronic databases for randomised 
controlled trials reporting clinical outcomes following adjunctive antibiotic therapy for 
patients divided by baseline microbiological profiles.  
Results: The initial search resulted in 643 papers, reduced to 5 after screening and author 
contact. Four of these studies were suitable for a fixed effects two-stage individual 
participant data meta-analysis adjusted for baseline data. Collectively, adjunctive 
Amoxicillin and Metronidazole yielded superior clinical results (measured as reduction of 
PPDs) compared to placebo. No significant differences were detected for the effect of 
adjunctive antibiotics by detection of A. actinomycetemcomitans on PPDs ≥ 5 mm 
(WMD=1.16, 95% CI[-5.37, 7.68], I2=37.8%) or other clinical outcomes .  All included 
studies had low risk of bias. 
Conclusion: There is no evidence to suggest that baseline detection of 
periodontopathogenic bacteria should be used as criterion for prescribing adjunctive 
antibiotics, although only limited information on microbial data and specific antimicrobials 
were available for analysis. 
 
CLINICAL RELEVANCE 
Scientific rationale for study: It is not clear if adjunctive systemic antimicrobials are more 
effective in patients with specific periodontopathogenic bacteria. Principal findings: 
adjunctive Amoxicillin and Metronidazole were effective at improving periodontal clinical 
outcomes irrespective of subgingival detection of A. actinomycetemcomitans. Practical 
implications: based on current evidence, it is hard to justify microbiologically-guided 
adjunctive antibiotic use. More studies on this topic are required to provide guidelines for 
the use of personalised antimicrobial therapy. 
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BACKGROUND  
The use of antibiotic treatment as adjunctive to non-surgical periodontal therapy was initially 
introduced to tackle the microbial aetiology of periodontitis (Baer & Socransky 1979) and later 
on more specifically with the main aim to eliminate periodontopathogenic bacteria (such as 
Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis) which are otherwise 
likely to persist following mechanical biofilm removal only (van Winkelhoff et al., 1989). 
Adjunctive antibiotic treatment was initially restricted to patients with juvenile periodontitis 
(Lindhe & Liljenberg, 1984), but then sometimes also extended to patients with chronic, adult 
forms of periodontitis (Winkel et al., 2001) and/or to diabetic patients with periodontitis 
(Grellmann et al., 2001). The adjunctive use of systemic antibiotics has shown to be beneficial, 
especially but not exclusively in patients with aggressive periodontitis, in terms of 
improvements in clinical parameters (probing pocket depths, PPD, and clinical attachment 
levels, CAL) compared with placebo (Sgolastra et al., 2012; Smiley et al., 2015; Zandbergen 
et al., 2001; Herrera et al., 2002; Haffajee et al., 2003; Jepsen & Jepsen, 2016), although the 
long-term stability of such improvements is probably highly influenced by the supportive 
periodontal therapy regime adopted (Ramberg et al., 2001). However, conflicting evidence has 
been reported on whether the baseline subgingival detection of the specific bacteria that the 
antibiotics have been introduced to target, affects the clinical improvements when antibiotics 
are given or not (Cionca et al., 2010; Guerrero et al., 2014). A recent retrospective study 
suggested that microbiological analysis could inform a clinically-based decision for the 
adjunctive use of systemic antibiotics (Eick et al., 2018). Overall, it is unclear whether subjects 
harboring specific pathogens subgingivally before treatment may benefit more from the 
adjunctive antibiotics compared to subjects not harboring them. The reliability of antimicrobial 
testing prior to treatment has also been questioned (Mellado et al., 2001; Salkin et al., 2003). 
Therefore, empirical antibiotic use often takes place, without prior knowledge of the 
subgingival microbial composition.   
A recent survey of U.S. periodontists revealed that prescription, initiation, and duration of 
antibiotics varied considerably in many of the treatments, suggesting that guidelines and 
protocols are needed for antibiotic use (Froum & Weinberg, 2015). Given the widespread 
concerns about antibiotic resistance and consequent need to try and reduce antibiotic 
prescriptions, there is an urge to develop guidelines for antibiotic prescription in periodontal 
therapy (Rams et al., 2014). In this respect, a personalised approach to treatment, where 
baseline microbial composition informs decisions on adjunctive antibiotic therapy, may be 
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beneficial. However, it is not clear whether such approach could be justified based on existing 
evidence. 
 
The aim of this systematic review was to assess if the baseline presence of 
periodontopathogenic bacteria (including but not restricted to A. actinomycetemcomitans, P. 
gingivalis and Tannerella forsythia) influence the clinical benefits of a course of systemic 
antimicrobials (including but not restricted to amoxicillin plus metronidazole) used as adjuncts 
to non-surgical periodontal therapy. The PICO question outline was: 
- Population: subjects with periodontitis receiving systemic antimicrobials or placebo as 
adjunct to non-surgical periodontal therapy  
- Intervention: non-surgical periodontal therapy + systemic antimicrobials (or placebo)  
- Comparisons: pre-treatment detection or not of specific subgingival bacteria   
- Outcomes: changes in PPD and CAL at 6 months follow-up 
 
MATERIALS AND METHODS 
A systematic review protocol was written in the planning stages and the PRISMA checklist 
(Moher et al., 2009) was followed both in the planning and reporting of the review (checklist 
attached as supplemental material 1). The protocol was registered with PROSPERO (number 
CRD42018107899). 
 
Focused question 
What is the clinical benefit (measured as PPD and CAL reduction) in periodontitis patients 
taking adjunctive systemic antimicrobials to non-surgical therapy, depending on pre-treatment 
detection of periodontopathogenic bacteria?  
-  
 
Eligibility criteria 
The inclusion criteria for studies in the systematic review were: 
o Study design: randomised controlled trials (RCT) investigating the use of 
systemic antimicrobials as adjuncts to non-surgical periodontal therapy  
o Reporting clinical outcome of treatment in subjects divided by subgingival 
bacteria detection pre-treatment  
o At least 6-months follow-up 
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Choice of main outcomes 
The outcome for the review was the change in PPD and CAL 6 months after treatment in 
patients divided by treatment (antimicrobial vs. placebo) and by baseline detection of 
subgingival bacteria.  
 
Information sources 
The search was conducted through the electronic databases MEDLINE, EMBASE and 
Cochrane library up to 24th July 2018 and was complemented by a search through the reference 
lists of included studies. No language restriction was included in the initial search. Among 
published literature, peer-reviewed studies, reports, book chapters and conference abstracts 
were screened. Narrative or systematic reviews on the topic were searched in order to identify 
suitable papers. The search was complemented by searches on the Open Grey database and by 
a hand search in Journal of Dental Research, Journal of Periodontology, Journal of Clinical 
Periodontology and Journal of Periodontal Research from 2000 until 2018 and by contacting 
editors of the journals above to enquire about any potentially relevant papers soon to be 
published. An attempt was also made to contact authors of potentially-relevant papers in order 
to obtain raw data and to clarify potential inclusion. 
 
The MEDLINE search strategy (adapted to the other databases) is described below: 
(‘‘Periodontitis’’[MeSH] OR ‘‘Chronic Periodontitis’’[MeSH] OR ‘‘Periodontal 
Diseases’’[MeSH] OR ‘‘Periodontal Pocket’’[MeSH] OR ‘‘Periodontal Attachment 
Loss’’[MeSHh] OR periodontitis OR periodontal disease* OR periodontal pocket* OR 
attachment loss OR pocket depth OR periodontal non surgical treatment OR periodontal non 
surgical therapy OR scaling root planing OR dental scaling OR periodontal treatment OR 
periodontal therapy OR ‘‘Dental Scaling’’[MeSH] OR ‘‘Root Planing’’[MeSH]) 
AND (‘‘Antibiotic’’[MeSH] OR ‘‘Antimicrobial’’) 
AND (‘‘Microbial testing’’ OR ‘‘16s’’ ‘‘Microbial analysis’’ OR ‘‘PCR’’ OR ‘‘Culture’’ OR 
‘‘Checkerboard’’ OR ‘‘Bacteria’’) 
AND ("Treatment Outcome" OR "probing pocket depth" OR "PPD" OR "clinical attachment 
level" OR "CAL"). This search was modified and adapted to the other databases. 
 
Study selection 
Study selection was conducted by two independent reviewers (LN, VK) in the following stages: 
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1. Initial screening of potentially-suitable titles and abstracts against the inclusion 
criteria to identify potentially relevant papers  
2. Screening of the full papers identified as possibly relevant in the initial screening 
Studies were excluded if not meeting the inclusion criteria. Following the screening of titles 
and abstracts (step 1), the studies included by both reviewers were compared and a complete 
database for step 2 was formed joining all studies selected by at least one reviewer. Following 
step 2, in case of a disagreement between reviewers, the decision about study eligibility was 
made trying to reach a consensus between the two reviewers. Emails were sent to the authors 
of excluded papers, enquiring whether relevant unpublished data could be obtained. When this 
was possible, studies were included. The agreement value between reviewers was calculated 
after step 1 and after step 2 using Kappa statistics. 
 
Data collection process/ data items  
A standardized data extraction form was used to record data from each included study, 
encompassing number of patients, demographics, definition and diagnosis of periodontitis, 
clinical methods (assessment and treatment), antibiotic/placebo regime, length of follow-up, 
number of patients lost to follow-up, methods for bacterial detection, clinical outcomes 
(divided by treatment groups and by bacterial detection groups), microbial outcomes and 
patient-reported outcomes. 
 
Risk of bias in individual studies 
The quality of the included studies was assessed through risk of bias analysis as it could impact 
on the overall results and conclusions (‘Systematic reviews, CRD’s guidance for undertaking 
reviews in health care’, University of York, 2008). The Cochrane Collaborations tool was used 
for assessing risk of bias (Higgins & Green, 2011) (see Appendix 1). 
  
Summary measures/Synthesis of results/ Statistical methods 
Study results were categorized according to periodontal treatment (antibiotic/placebo) and 
bacterial detection (yes/no). Two-stage, fixed effect individual participant data meta-analyses 
were performed for all outcomes using the Stata module ipdmetan (Fisher, 2015). The main 
outcome was reduction of PPD ≥ 5 mm at 6 months. Unbiased estimates of the weighted mean 
difference (WMD) of treatment effects between bacterial detection groups were obtained 
estimating the treatment-bacterial detection interaction within each study separately and 
subsequently pooling these estimates. Estimates of WMDs are presented with associated 95% 
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confidence intervals (95% CI) Forest plots were produced to graphically represent the 
differences in treatment effects between studies and the overall pooled estimate. Heterogeneity 
was assessed first using clinical judgement and then statistical heterogeneity is described using 
the p-value for the chi-squared test statistic Q, denoted pQ,  and the I
2 index Higginsand 
Thompson, 2002. Funnel plots were used to explore the presence of publication bias.   
 
RESULTS  
Study selection 
Figure 1 reports the flowchart representing study selection and inclusion. The initial search 
identified 611 PubMed, 4 Embase, and 85 Cochrane Library database articles, with a total of 
643 papers after de-duplication. No additional papers were identified by the Open Grey search, 
while 3 were identified by hand search, resulting in a total of 646 papers. Following first-stage 
screening of titles and abstracts, 64 articles qualified for full-text screening (considered 
potentially suitable by at least one reviewer). After full text reading, 3 articles met the defined 
inclusion criteria and 61 were excluded (reported as supplemental material 2). The reasons for 
exclusion were as follows: 41 did not report clinical response divided by microbial detection, 
7 had no control group, 3 were not RCTs, 3 had follow-up <6 months, 2 studies did not use 
antibiotics as adjuncts to SRP, 2 were duplicate reports and one each did not include systemic 
antibiotics, did not report PPD and CAL or was not retrievable. Emails were sent to 
corresponding authors of the screened papers not reporting response divided by microbial 
detection. No contact was found for 9 of them, and emails were sent to authors of the remaining 
33. Following this, no response was obtained for 27 papers, while 4 authors replied that they 
could not retrieve the requested data and 2 authors provided individual patient data relevant to 
the present review were provided resulting in inclusion in the review (Mestnik et al., 2012; 
Soares et al., 2014). This resulted in 5 papers finally being included. The kappa value for inter-
reviewer agreement was 0.54 (95% CI= 0.42-0.67) at title and abstract screening (93.9% 
agreement) and 0.85 (95% CI= 0.56-1) at full text reading (98.3% agreement). 
 
Study characteristics 
Table 1 reports the characteristics of the sample included in the reviewed studies. All 5 included 
articles were written in English. The countries where the studies were conducted were Brazil 
(2 studies), United Kingdom, Switzerland and Colombia (one study each). The patient sample 
ranged from 30 (Mestnik et al., 2012) to 118 patients (Soares et al., 2014). All studies were 
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RCTs and were published from 2005 to 2017. The target population was generalised aggressive 
periodontitis (GAgP) in 3 studies (Guerrero et al., 2014; Mestnik et al., 2012; Ardila and 
Guzman, 2017) and chronic periodontitis (CP) in 2 studies, including moderate CP (Cionca et 
al., 2010) and moderate to severe CP (Soares et al., 2014). The study follow-ups ranged from 
6 and 12 months. The subgingival debridement regime ranged from a full-mouth approach in 
one (Ardila and Guzman, 2017) or two sessions within 24 hours (Guerrero et al., 2014) or 48 
hours (Cionca et al., 2010) to a staged approach over 14 days (Mestnik et al., 2012; Soares et 
al., 2014). The antibiotic regimes varied too, including Amoxicillin+ Metronidazole for most 
studies, albeit with differences in dose and duration (Cionca et al., 2010; Guerrero et al., 2014; 
Mestnik et al., 2012), an additional arm with Metronidazole alone (Soares et al., 2014) and in 
one case Moxifloxacin (Ardila & Guzman, 2017). A placebo was used for control patients in 
all included studies. It is worth noting that none of the included studies had differences in 
clinical response by baseline microbial profile as the main study outcome. 
 
Subgingival plaque sampling was carried out by paper points or curettes, while microbiological 
methods were also heterogeneous, including cultures (Ardila & Guzman, 2017), polymerase 
chain reaction (PCR) (Cionca et al., 2010; Guerrero et al., 2014) or checkerboard (Mestnik et 
al., 2012; Soares et al., 2014). Definition of ‘A. actinomycetemcomitans +ve’ was based on 
level of A. actinomycetemcomitans at least 105, a threshold suggested as relevant in previous 
literature (Socransky et al. 1998). Given the heterogeneity in microbial analysis, this threshold 
was considered in at least 1 site for studies where samples were not pooled (Mestnik et al., 
2012; Soares et al., 2014; Ardila & Guzman, 2017) and for detection of A. 
actinomycetemcomitans in papers using PCR from pooled samples (Cionca et al., 2010; 
Guerrero et al., 2014), where the counts for single sites could not be ascertained, but where in 
any case most of average counts were >105. By these definitions, a substantial percentage of 
patients was A. actinomycetemcomitans +ve (respectively 25% (Cionca et al., 2010), 49 % 
(Guerrero et al., 2014), 50% (Ardila & Guzman, 2017), 33% (Soares et al., 2014) and 80% 
(Mestnik et al., 2012)).  
 
Synthesis of results 
All included studies reported clinical benefits with the use of the adjunctive antibiotics, 
measured as increased reductions in PPD and CAL in the test compared with control groups 
(Table 1). Four studies, all using Amoxicillin and Metronidazole as adjuncts, were included in 
a meta-analysis for reduction in the number of PPD ≥ 5 mm at 6 months (see supplemental 
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material 3), showing increased reduction in the number of PPD ≥ 5 mm for test vs. control 
group, with WMD = 8.81 sites with PPDs (95% CI= [5.85; 11.76], p<0.001), albeit with high 
heterogeneity (I2=82.1%, pQ=0.001).  
 
When baseline subgingival microbial data were considered, Ardila and co-workers (using 
Moxifloxacin as adjunct) reported differences favouring the antibiotic group in A. 
actinomycetemcomitans +ve vs.  A. actinomycetemcomitans -ve for PPDs ≥7 mm (1.96 mm vs. 
1.14 mm respectively) and for PPDs 4-6 mm (0.92 mm vs. 0.51 mm respectively) (Ardila and 
Guzman, 2017). Similarly, Guerrero and co-workers reported that the percentage of sites 
changing from ≥ 5 mm to ≤ 4mm PPDs at 6 months was 80.9% for A. actinomycetemcomitans 
+ve individuals treated with adjunctive antibiotics, compared to 71.1% for A. 
actinomycetemcomitans -ve individuals treated with adjunctive antibiotics (Guerrero et al., 
2014). In contrast, when no antibiotics were prescribed, the change from ≥ 5 mm to ≤ 4 mm 
PPDs was found to be 52.6% for A. actinomycetemcomitans +ve and 60.9% for A. 
actinomycetemcomitans -ve individuals. Overall, both Guerrero and co-workers and Ardila and 
co-workers suggested that all patients benefitted from the antibiotic adjunct, although its 
clinical effect seemed to be more pronounced (but not statistically significant) in A. 
actinomycetemcomitans +ve patients (Guerrero et al., 2014; Ardila & Guzman, 2017). On the 
contrary, Cionca and co-workers concluded that the adjunctive clinical benefits attributable to 
the antibiotic were obtained regardless of the baseline presence or absence of the six studied 
periodontal pathogens (Cionca et al., 2010). The other two included papers did not comment 
on clinical results for antibiotic and placebo divided by baseline microbial detection, but data 
were provided to the authors of this review (Mestnik et al., 2012; Soares et al., 2014).  
 
Fixed effects meta-analysis (Figure 2) of the four papers using adjunctive Amoxicillin and 
Metronidazole revealed no significant differences in the effect of the antibiotic regime on the 
reduction of PPD ≥ 5 mm at 6 months (adjusted for their baseline number) based on the baseline 
detection of A. actinomycetemcomitans, with moderate heterogeneity (I2=37.8%, pQ=0.185).   
 
Meta-analysis for other available clinical data was possible for three papers (Guerrero et al., 
2014; Mestnik et al., 2012; Soares et al., 2014) using adjunctive Amoxicillin and 
Metronidazole. Meta-analyses revealed no statistically significant differences in the effect of 
the antibiotic regime for A. actinomycetemcomitans +ve vs. A. actinomycetemcomitans -ve for 
mean PPD at 6 months in sites which had PPD≥7 mm at baseline (Figure 3), mean CAL at 6 
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months in sites which had PPD≥7 mm at baseline (Figure 4) and mean CAL at 6 months in 
sites which had PPD 4-6 mm at baseline (Figure 5). As is common in the meta-analysis of a 
small number of studies with small sample sizes Cochran’s Q test statistic was smaller than the 
degrees of freedom for these three outcome measures leading to a negative estimate of I2 which 
was by convention set to zero (Higgins & Thompson, 2002). Forest plots indicate that there 
was some heterogeneity which was deemed small enough to justify fixed effect meta-analysis 
for all outcomes. 
 
All these 6-months outcomes (mean PPD and CAL in sites with PPD≥7 mm at baseline and 
mean CAL in sites with PPD 4-6 mm at baseline) showed improvements in the test vs. placebo 
meta-analyses, irrespective of   A. actinomycetemcomitans status (supplemental material 4, 5 
and 6). 
 
Very sparse data were available for the other periodontopathogenic bacteria examined, such as 
P. gingivalis or T. forsythia, preventing any conclusion to be drawn. 
 
Risk of bias assessment  
Risk of bias analyses (Table 2) showed that most items were considered at low risk of bias. 
Overall, all studies had low risk of bias. A funnel plot of the main outcome PPD ≥ 5mm 
(supplemental material 7) provides no evidence of publication bias. 
 
DISCUSSION 
This systematic review shows that the adjunctive antimicrobial regime of Amoxicillin and 
Metronidazole is effective in reducing pocket depths (measured as PPD ≥ 5mm reduction 6 
months after treatment), irrespective of A. actinomycetemcomitans detection. Similarly, meta-
analyses of papers reporting 6-months results of mean PPDs in moderate (4-6 mm PPDs) and 
deep (≥ 7 mm PPD) pockets and mean CAL in pockets ≥7 mm revealed no significant 
difference by baseline A. actinomycetemcomitans detection. No meta-analysis was possible 
based on other bacteria or other antibiotics, due to a paucity of data in the 5 included papers. 
Therefore, although some papers (Guerrero et al., 2014; Ardila & Guzman, 2017) suggested 
that the adjunctive antibiotics may be more effective in improving clinical outcomes in patients 
carrying some specific periodontopathogenic bacteria such as A. actinomycetemcomitans, this 
is not supported by the evidence produced by this review.  
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This paper supports the evidence  that some systemic antimicrobials provide additional clinical 
reductions in PPD and CAL when used as adjuncts to non-surgical periodontal therapy, as 
clarified by several independent studies and meta-analyses (Jepsen & Jepsen, 2016; Pretzl et 
al., 2018). However, side effects of systemic antibiotics including risk of 
allergic/hypersensitivity reactions and onset of antibiotic resistance limit their widespread use. 
Clinical efficacy and adverse events are thus the two main opposite arguments used by ‘pro-
antibiotics’ and ‘anti-antibiotics’ periodontists. But what if we could use the principles of 
personalised medicine (Duarte & Spencer, 2016) to select patients who could benefit the most 
from the adjunctive antibiotics, therefore moving away from empirical, ‘one size fits all’ 
antibiotic use? Some studies employed a targeted microbial approach for the elimination of 
periodontopathogenic bacteria based on baseline microbial profiles (van Winkelhoff et al. 
1989; Goene’ et al. 1990). Clinical diagnosis (aggressive vs. chronic periodontitis) was 
sometimes considered as a rough guide for antibiotic prescription, given the biggest magnitude 
of adjunctive clinical effect of antibiotics in aggressive periodontitis (AgP) (Haffajee et al., 
2003). It has also been suggested that patients with deep pockets, 'active' disease (Herrera et 
al., 2002) or specific microbiological profiles (van Winkelhoff & Winkel, 2005) might benefit 
more from this adjunctive therapy. In the new post-AgP/CP era (Tonetti et al., 2018), baseline 
subgingival microbial profiling could become a useful tool for decision on adjunctive antibiotic 
use in periodontal non-surgical therapy. A recent study investigating A. 
actinomycetemcomitans isolates in AgP revealed high levels of resistance to systemic 
antibiotics, suggesting the need for antimicrobial susceptibility analysis prior to systemic use 
of antibiotics concomitantly to periodontal therapy (Akrivopoulou et al., 2017). However, we 
found no support for this approach based on meta-analysis of the papers included in this review.  
 
When discussing this, it is important to remember that none of the studies included in this 
review had differences in clinical response by baseline microbial profile as the main study 
outcome. The only study detected in our search which set out to answer this question, although 
it is not clear how it was powered, had a 3-month follow-up and as such did not qualify for this 
systematic review (Mombelli et al., 2013). In that study, 82 periodontitis patients (half of whom 
had A. actinomycetemcomitans detected subgingivally) underwent non-surgical periodontal 
therapy with or without adjunctive antibiotics. The results led to the conclusion that patients 
benefited from the antibiotics irrespective of sex, age, or smoking status and baseline A. 
actinomycetemcomitans detection. Interestingly, in a post-hoc subgroup analysis molars 
benefited significantly more from the antibiotics than non-molars (Mombelli et al., 2013). 
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Low risk of bias was detected in all the papers included in this review. Areas of potential 
improvement for further reducing risk of bias, based on our assessment, are more specific 
descriptions of how knowledge of allocated interventions was concealed from patients and 
researchers (performance bias) and of selective outcome reporting (reporting bias). 
 
An important limitation of these analyses is the lack of sophistication of microbiological 
analysis. In other words, no specific results relative to different strains of bacteria, in particular 
A. actinomycetemcomitans, were reported, while it is clearly emerging that different strains of 
the same bacteria may have very different clinical effects (Damgaard et al., 2017). Furthermore, 
heterogeneity in the microbiological analyses, with different sampling strategies and 
microbiological technologies (PCR, culture, checkerboard): as well as in the clinical protocols 
(different antibiotic regimes and different approaches such as quadrant sessions, full-mouth 
disinfection or chlorhexidine irrigations) employed in the different studies may have had an 
impact in our findings. The inclusion of smokers in some of the included studies may have also 
influenced the observed results. This review also suffers from inability to retrieve more 
unpublished data on clinical outcomes divided by microbiological status from published 
clinical trials. Aggressive and chronic periodontitis cases were pooled together in the meta-
analysis, in line with the new classification of periodontitis (Tonetti et al. 2018). It could be 
argued that cases should have been separated by disease severity (mild-moderate-severe); 
however, results seemed consistent both for sites with PPD ≥ 5 mm and for sites with more 
advanced periodontitis (PPD ≥ 7 mm). 
 
As part of a drive to reduce unnecessary use of antibiotics and antimicrobial resistance, 
effective diagnostic microbial testing is now encouraged by governing bodies (WHO Global 
Action Plan on Antibiotic Resistance 2015, EU Guidelines for the prudent use of antimicrobials 
in human health 2017). However, entering the era of personalised medicine, this systematic 
review suggests that there is not enough evidence to support or completely disregard that 
baseline detection of periodontopathogenic bacteria should be used as criterion for prescribing 
adjunctive antibiotics, although only limited information on microbial data and specific 
antibiotics were available for analysis. Other criteria such as disease severity may have stronger 
ground to be employed as part of the decision on whether to use adjunctive antibiotics or not. 
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Furthermore, this study stresses the importance of open access databases, which could help in 
the retrieval of more data for secondary analyses, when original data of interest are not reported 
in the papers and not easily available.  
 
ACKNOWLEDGMENTS 
The help of Prof. Magda Feres, Prof. Marcelo de Faveri and Prof. Andrea Mombelli in 
providing individual patient data for meta-analysis is gratefully acknowledged.  
Disclosure Statement: The authors have stated explicitly that there are no conflicts of interest 
to disclose in connection with this article. 
 
REFERENCES 
Akrivopoulou, C., Green, I.M., Donos, N., Nair, S.P., Ready, D. (2017) Aggregatibacter 
actinomycetemcomitans serotype prevalence and antibiotic resistance in a UK population with 
periodontitis. Journal of Global Antimicrobial Resistance 10:54-58. 
Ardila, C.M. & Guzman, I.C. (2017) Benefits of adjunctive moxifloxacin in generalized 
aggressive periodontitis: a subgroup analyses in Aggregatibacter actinomycetemcomitans-
positive/negative patients from a clinical trial. Journal of Investigative and Clinical Dentistry, 
8, 2. doi: 10.1111/jicd.12197 
Baer, P.N. & Socransky, S.S. (1979) Periodontosis: case report with long-term follow-up. 
Periodontal Case Reports 1979;1(1):1-6. 
Cionca, N., Giannopoulou, C., Ugolotti, G., Mombelli, A. (2010) Microbiologic testing and 
outcomes of full-mouth scaling and root planing with or without amoxicillin/metronidazole in 
chronic periodontitis. Journal of Periodontology 81(1), 15-23. doi: 10.1902/jop.2009.090390.  
Damgaard, C., Reinholdt, J., Palarasah, Y., Enevold, C., Nielsen, C., Brimnes, M.K., 
Holmstrup, P., Nielsen, C.H. (2017) In vitro complement activation, adherence to red blood 
cells and induction of mononuclear cell cytokine production by four strains of Aggregatibacter 
actinomycetemcomitans with different fimbriation and expression of leukotoxin. Journal of 
Periodontal Research, 52(3), 485-496. doi: 10.1111/jre.12414. 
Duarte, T.T. & Spencer, C.T. (2016) Personalized Proteomics: The Future of Precision 
Medicine. Proteomes, 4(4).  doi:10.3390/proteomes4040029 
Eick, S., Nydegger, J., Bürgin, W., Salvi, G.E., Sculean, A., Ramseier C. (2018) 
Microbiological analysis and the outcomes of periodontal treatment with or without adjunctive 
systemic antibiotics-a retrospective study. Clinical Oral Investigations doi: 10.1007/s00784-
018-2392-3.  
14 
 
EU Guidelines for the prudent use of antimicrobials in human health. COMMISSION 
NOTICE. Official Journal of the European Union (2017/C 212/01). 
Fisher, D.J. (2015) Two-stage individual participant data meta-analysis and generalized forest 
plots. The Stata Journal 15(2), pp. 369–396. 
Froum, S.J. & Weinberg, M.A. (2015) An Evaluation of Antibiotic Use in Periodontal and 
Implant Practices. International Journal of Periodontics & Restorative Dentistry, 35(4), 481-
7. doi: 10.11607/prd.2488. 
Goené, R.J., Winkel, E.G., Abbas, F., Rodenburg, J.P., van Winkelhoff, A.J., de Graaff, J. 
(1990) Microbiology in diagnosis and treatment of severe periodontitis. A report of four cases. 
Journal of Periodontology 61, 61-4. 
Grellmann, A.P., Sfreddo, C.S., Maier, J., Lenzi, T.L., Zanatta, F.B. (2016) Systemic 
antimicrobials adjuvant to periodontal therapy in diabetic subjects: a meta-analysis. Journal of 
Clinical Periodontology, 43(3), 250-60. doi: 10.1111/jcpe.12514. 
Guerrero, A., Nibali, L., Lambertenghi, R., Ready, D., Suvan, J., Griffiths, G.S., Wilson, M., 
Tonetti, M.S. (2014) Impact of baseline microbiological status on clinical outcomes in 
generalized aggressive periodontitis patients treated with or without adjunctive amoxicillin and 
metronidazole: an exploratory analysis from a randomized controlled clinical trial. Journal of 
Clinical Periodontology, 41(11), 1080-9. doi: 10.1111/jcpe.12299 
Haffajee, A.D., Socransky, S.S., Gunsolley, J.C. (2003) Systemic anti-infective periodontal 
therapy. A systematic review. Annals of Periodontology, 8(1), 115-81.  doi: 
10.1902/annals.2003.8.1.115 
Herrera, D., Sanz, M., Jepsen, S., Needleman, I., Roldán, S. (2002) A systematic review on the 
effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis 
patients. Journal of Clinical Periodontology, 29 Suppl 3, 136-62. 
Higgins, J.P.T. & Green, S. (2011) Cochrane Handbook for Systematic Reviews of 
Interventions version 5.1.0. London: The Cochrane Collaboration. 
Higgins, J.P.T. & Thompson, S.G. (2002) Quantifying heterogeneity in a meta-analysis. 
Statistics in Medicine., 21(11):1539–58. doi: 10.1002/sim.1186. 
Jepsen, K. & Jepsen, S. (2016) Antibiotics/antimicrobials: systemic and local administration in 
the therapy of mild to moderately advanced periodontitis. Periodontology 2000, 71(1), 82-112. 
doi: 10.1111/prd.12121. 
Lindhe, J. & Liljenberg, B. (1984) Treatment of localized juvenile periodontitis. Results after 
5 years.  Journal of Clinical Periodontology, 11(6), 399-410.  
Mellado, J.R., Freedman, A.L., Salkin, L.M., Stein, M.D., Schneider, D.B., Cutler, R.H. (2001) 
The clinical relevance of microbiologic testing: a comparative analysis of microbiologic 
15 
 
samples secured from the same sites and cultured in two independent laboratories. International 
Journal of Periodontics & Restorative Dentistry, 21(3), 232-9. 
Mestnik, M.J., Feres, M., Figueiredo, L.C., Soares, G., Teles, R.P., Fermiano, D., Duarte, P.M., 
Faveri, M. (2012) The effects of adjunctive metronidazole plus amoxicillin in the treatment of 
generalised aggressive periodontitis. A 1-year double-blinded, placebo-controlled, randomized 
clinical trial. Journal of Clinical Periodontology, 39, 955-961.  doi: 10.1111/j.1600-
051X.2012.01932.x.  
Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G. (2009) PRISMA Group. Preferred reporting 
items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical 
Epidemiology, 62(10), 1006-12. doi: 10.1016/j.jclinepi.2009.06.005.  
Mombelli, A., Cionca, N., Almaghlouth, A., Décaillet, F., Courvoisier, D.S., Giannopoulou, 
C. (2013) Are there specific benefits of amoxicillin plus metronidazole in Aggregatibacter 
actinomycetemcomitans-associated periodontitis? Double-masked, randomized clinical trial of 
efficacy and safety. Journal of Periodontology, 84(6), 715-24. doi: 10.1902/jop.2012.120281 
Pretzl, B., Sälzer, S., Ehmke, B., Schlagenhauf, U., Dannewitz, B., Dommisch, H., Eickholz, 
P., Jockel-Schneider, Y. (2018) Administration of systemic antibiotics during non-surgical 
periodontal therapy-a consensus report. Clinical Oral Investigations. doi: 10.1007/s00784-
018-2727-0 
Ramberg, P., Rosling, B., Serino, G., Hellström, M.K., Socransky, S.S., Lindhe, J. (2001) The 
long-term effect of systemic tetracycline used as an adjunct to non-surgical treatment of 
advanced periodontitis. Journal of Clinical Periodontology, 28(5), 446-52. 
Rams, T.E., Degener, J.E., van Winkelhoff, A.J. (2014) Antibiotic resistance in human chronic 
periodontitis microbiota. Journal of Periodontology, 85(1), 160-9. doi: 
10.1902/jop.2013.130142.  
Salkin, L.M., Freedman, A.L., Mellado, J.R., Stein, M.D., Schneider, D.B., Butler, L. (2003) 
The clinical relevance of microbiologic testing. Part 2: a comparative analysis of microbiologic 
samples secured simultaneously from the same sites and cultured in the same laboratory. 
International Journal of Periodontics & Restorative Dentistry, 23(2), 121-7. 
Sgolastra, F., Petrucci, A., Gatto, R., Monaco, A. (2012) Effectiveness of systemic 
amoxicillin/metronidazole as an adjunctive therapy to full-mouth scaling and root planing in 
the treatment of aggressive periodontitis: a systematic review and meta-analysis. Journal of 
Periodontology, 83(6), 731-43. doi: 10.1902/jop.2011.110432.  
Smiley, C.J., Tracy, S.L., Abt, E., Michalowicz, B.S., John, M.T., Gunsolley, J., Cobb, C.M., 
Rossmann, J., Harrel, S.K., Forrest, J.L., Hujoel, P.P., Noraian, K.W., Greenwell, H., Frantsve-
Hawley, J., Estrich, C., Hanson, N. (2015) Systematic review and meta-analysis on the 
nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or 
without adjuncts. Journal of the American Dental Association, 146(7), 508-24. doi: 
10.1016/j.adaj.2015.01.028. 
16 
 
Soares, G.M.S., Mendes, J.A.V., Silva, M.P., Faveri, M., Teles, R., Socransky, S.S., Wang, X., 
Figueiredo, L.C., Feres, M. (2014) Metronidazole alone or with amoxicillin as adjuncts to non-
surgical treatment of chronic periodontitis: a secondary analysis of microbiological results from 
a randomized clinical trial. Journal of Clinical Periodontology, 41, 366-376.  
Socransky, S.S., Haffajee, A.D., Cugini, M.A., Smith, C. & Kent, R.L. Jr. (1998) Microbial 
complexes in subgingival plaque. Journal of Clinical Periodontology 25, 134-144. 
Tonetti, M.S., Greenwell, H., Kornman, K.S. (2018) Staging and grading of periodontitis: 
Framework and proposal of a new classification and case definition. Journal of 
Periodontology, 89 Suppl 1, S159-S172. doi: 10.1002/JPER.18-0006. 
van Winkelhoff, A.J., Rodenburg, J.P., Goené, R.J., Abbas, F., Winkel, E.G., de Graaff, J. 
(1989) Metronidazole plus amoxycillin in the treatment of Actinobacillus 
actinomycetemcomitans associated periodontitis. Journal of Clinical Periodontology, 16(2), 
128-31.  
van Winkelhoff, A.J. & Winkel EG. (2005) Microbiological diagnostics in periodontics: 
biological significance and clinical validity. Periodontology 2000, 39, 40-52. 
doi:10.1111/j.1600-0757.2005.00116.x 
WHO Global Action Plan on Antimicrobial Resistance (2015). World Health Organization. 
Winkel, E.G., Van Winkelhoff, A.J., Timmerman, M.F., Van der Velden, U., Van der Weijden, 
G.A. (2001) Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. 
Journal of Clinical Periodontology, 28(4), 296-305. 
Zandbergen, D., Slot, D.E., Niederman, R., Van der Weijden, F.A. (2016) The concomitant 
administration of systemic amoxicillin and metronidazole compared to scaling and root planing 
alone in treating periodontitis: a systematic review. BMC Oral Health, 16, 27. doi: 
10.1186/s12903-015-0123-6.  
 
FIGURE LEGENDS 
Figure 1. Flowchart representing study selection and inclusion 
Figure 2. Fixed effects meta-analysis of papers using adjunctive Amoxicillin and 
Metronidazole on the reduction of PPD ≥ 5mm to PPD<5mm at 6 months (adjusted for their 
baseline number) based on the baseline detection of A. actinomycetemcomitans 
Figure 3. Fixed effects meta-analysis of papers using adjunctive Amoxicillin and 
Metronidazole for mean PPD at 6 months in sites which had PPD≥7mm at baseline based on 
baseline detection of A. actinomycetemcomitans  
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Figure 4. Fixed effects meta-analysis of papers using adjunctive Amoxicillin and 
Metronidazole for mean CAL at 6 months in sites which had PPD≥7mm at baseline based on 
baseline detection of A. actinomycetemcomitans  
Figure 5. Fixed effects meta-analysis of papers using adjunctive Amoxicillin and 
Metronidazole for mean CAL at 6 months in sites which had PPD 4-6mm at baseline based on 
baseline detection of A. actinomycetemcomitans. 
